ArticleJournal of pharmaceutical policy and practice2020
Integrating pharmaceutical systems strengthening in the current global health scenario: three 'uncomfortable truths'.
Article in Journal of pharmaceutical policy and practice, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Regulatory and HTA framework for herbal medicines in Indonesia.Journal of pharmaceutical policy and practice · 2026Review
- Rapid review of the ideal clinic realisation and maintenance programme among primary healthcare providers in the Gauteng Province, South Africa.BMJ open quality · 2025Article
- Proposed framework for medication delivery system in the Jordanian public health sector.BMC medical informatics and decision making · 2024Article
- Building an effective medicines optimisation model: a health system approach.International journal of clinical pharmacy · 2024Article
- Making the investment case for national regulatory authorities.Journal of pharmaceutical policy and practice · 2021Article
- Understanding the factors influencing healthcare providers' burnout during the outbreak of COVID-19 in Jordanian hospitals.Journal of pharmaceutical policy and practice · 2020Article
- The importance of visual inspection in national quality assurance systems for medicines.Journal of pharmaceutical policy and practice · 2020Article
- Mental health issues impacting pharmacists during COVID-19.Journal of pharmaceutical policy and practice · 2020Article
- Assessing the performance of local pharmaceutical systems: An analytical approach to improve access to medicine.The journal of medicine accessReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The response to emergency public health challenges such as HIV, TB, and malaria has been successful in mobilising resources and scaling up treatment for communicable diseases. However, many of the remaining challenges in improving access to and appropriate use of medicines and services require pharmaceutical systems strengthening. Incorporating pharmaceutical systems strengthening into global health programmes requires recognition of a few 'truths'. Systems strengthening is a lengthy and resource-intensive process that requires sustained engagement, which may not align with the short time frame for achieving targets in vertical-oriented programmes. Further, there is a lack of clarity on what key metrics associated with population and patient level outcomes should be tracked for systems strengthening interventions. This can hinder advocacy and communication with decision makers regarding health systems investments. Moving forward, it is important to find ways to balance the inherent tensions between the short-term focus on the efficiency of vertical programmes and broader, longer-term health and development objectives. Global health programme design should also shift away from a narrow view of medicines primarily as an input commodity to a more comprehensive view that recognizes the various structures and processes and their interactions within the broader health system that help ensure access to and appropriate use of medicines and related services.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.